Alvonib 80 mg (Osimertinib) Tablets

Alvonib 80 mg contains Osimertinib, a targeted anticancer medicine used in specific types of EGFR mutation-positive non-small cell lung cancer (NSCLC). It works by selectively inhibiting abnormal epidermal growth factor receptor (EGFR) activity that contributes to cancer cell growth and spread.

Therapeutic Effects:

• Helps slow or inhibit the growth of EGFR mutation-positive lung cancer cells.
• Supports disease control in eligible patients with locally advanced or metastatic NSCLC.
• May help reduce the progression of cancer in patients with specific EGFR genetic alterations.
• Used as part of individualized treatment plans under specialist supervision.
• Contributes to improved management of certain forms of non-small cell lung cancer.

Active Ingredient:

• Osimertinib 80 mg

Composition:

Each film-coated tablet contains Osimertinib equivalent to 80 mg as the active pharmaceutical ingredient. The formulation may also include pharmaceutical excipients necessary for tablet stability, manufacturing consistency, and oral administration.

Generic Name: Osimertinib
Strength: 80 mg
Dosage Form: Film-Coated Tablet

Active Ingredient:

• Osimertinib 80 mg

Composition:

Each film-coated tablet contains Osimertinib equivalent to 80 mg as the active pharmaceutical ingredient. The formulation may also include pharmaceutical excipients necessary for tablet stability, manufacturing consistency, and oral administration.

Generic Name: Osimertinib
Strength: 80 mg
Dosage Form: Film-Coated Tablet

Dosage & Administration

Alvonib 80 mg should be used only under the guidance of a qualified healthcare professional experienced in oncology treatment.

Recommended Adult Dose:

• One 80 mg tablet taken orally once daily, or as directed by the treating physician.

Administration Instructions:

• Swallow the tablet whole with water.
• The medicine may be taken with or without food.
• Try to take the dose at approximately the same time each day.
• Do not crush, split, or chew the tablet unless specifically instructed by a healthcare provider.

Missed Dose:

• If a dose is missed, take it as soon as remembered unless the next scheduled dose is due within a short interval.
• Do not take a double dose to compensate for a missed dose.

Important Notes:

• Treatment duration depends on the patient's clinical response and physician assessment.
• Regular medical follow-up and monitoring may be required during therapy.
• Do not discontinue treatment without consulting your healthcare provider.

Disclaimer: Dosage recommendations may vary depending on the patient's medical condition, treatment response, and clinical judgment of the prescribing physician.